Germany’s CureVac COVID-19 vaccine flops in clinical trial
https://healthell.blogspot.com/2021/06/germanys-curevac-covid-19-vaccine-flops.html
Germany’s CureVac COVID-19 vaccine flops in clinical trial
German biopharmaceutical company CureVac's COVID-19 vaccine candidate revealed a disappointing 47% efficacy against COVID-19 disease of any severity, and failed to meet statistical success criteria in a late-stage trial, sending stocks tanking.
